ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "prevention"

  • Abstract Number: 1480 • ACR Convergence 2025

    Urinary Biomarkers Detect Proliferative Lupus Nephritis in SLE Patients with Subclinical Proteinuria.

    CHEN-YU LEE1, Rufei Lu2, Carla Guthridge2, Wade DeJager3, Jennifer Barnas4, Jennifer Anolik5, H Michael Belmont6, Judith James2, Jill Buyon7, Brad Rovin8, Michelle Petri9, Joel Guthridge2 and Andrea Fava1, 1Johns Hopkins University, Baltimore, MD, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, 4University of Rochester, Rochester, NY, 5University of Rochester Medical Center, Rochester, NY, 6NYU School of Medicine, New York, NY, 7NYU Grossman School of Medicine, New York, NY, 8The Ohio State University, Columbus, OH, 9Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: Early treatment is critical to prevent irreversible kidney damage in lupus nephritis (LN). Current guidelines recommend kidney biopsy when the urine protein-to-creatinine ratio (UPCR)…
  • Abstract Number: 0382 • ACR Convergence 2025

    Preventative Health Screening Practices Among 666 Women with Systemic Rheumatic Diseases from the Hospital for Special Surgery Rheumatology Women’s Reproductive Health and Wellness Cohort: A Cross-Sectional Analysis

    Sandhya shri Kannayiram1, Amaya Smole2, Lucy Masto3, Yongjay Kim4, Neha Nagpal1, Naiva Manuela Piatchou Donfack1, Deanna Jannat-Khah1, Lisa Mandl1, Sarah Lieber1, Caroline Siegel1, Michael Lockshin5, Lisa Sammaritano1 and Medha Barbhaiya1, 1HOSPITAL FOR SPECIAL SURGERY, New york, NY, 2Hospital for Special Surgery, Brooklyn, NY, 3Hospital for Special Surgery, San Francisco, CA, 4Hospital for Special Surgery, Englewood Cliffs, NJ, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Timely preventative health screenings in women with systemic rheumatic diseases (SRDs), especially those with other chronic conditions or who are on immunosuppressive therapy, may…
  • Abstract Number: 1447 • ACR Convergence 2025

    Long-term impact of secukinumab on the prevention of psoriatic arthritis in patients with psoriasis: a 5-year pooled analysis of the ERASURE, FIXTURE and SCULPTURE studies

    Ulrich Mrowietz1, Laura Coates2, Diamant Thaçi3, Mark Lebwohl4, Bardur Sigurgeirsson5, Richard B. Warren6, Richard G. Langley7, Andreas Clemens8, Cynthia Vizcaya8, Weibin Bao9, Kim Hoyt10, Lara Gómez11 and Robert Bissonnette12, 1Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, England, United Kingdom, 3Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany, 4Icahn School of Medicine at Mount Sinai, New York, NY, 5University of Iceland, Faculty of Medicine, Department of Dermatology,, Reykjavik, Iceland, 6Dermatology Centre, Northern Care Alliance, NHS Foundation Trust & Division of Musculoskeletal and Dermatological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom, 7Dalhousie University, Halifax, NS, Canada, 8Novartis Pharma AG, Basel, Switzerland, 9Novartis Pharmaceuticals Corporation, Hanover, NJ, 10Novartis Pharmaceuticals Corporation, East Hanover, NJ, 11Novartis Farmaceutica, Madrid, Spain, 12Innovaderm, Montreal, Québec, Canada

    Background/Purpose: Secukinumab is a fully human monoclonal antibody that selectively inhibits interleukin-17A, demonstrating robust and sustained efficacy in moderate to severe psoriasis (PsO) and psoriatic…
  • Abstract Number: 0366 • ACR Convergence 2025

    Dental Findings in Patients With Rheumatic Diseases and Its Association With Self-Perceived Oral Health

    Fernanda M. Garcia-Garcia1, Margarita Isabel Alarcon-Jarquin2, Vanessa L. Lopez-Flores2, Gabriel P. Castro-Cruz3, Carlos I. Estrada-Anguiano3, Jennifer Garcia-Bravo3, Aleydis Gonzalez-Melendez3, Gabriel Figueroa-Parra3, Dionicio A. Galarza-Delgado1 and Janett C. Riega-Torres4, 1Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico

    Background/Purpose: Oral health conditions are frequent in patients with rheumatic diseases and can impact daily function and quality of life. Factors such as chronic inflammation…
  • Abstract Number: 2653 • ACR Convergence 2025

    First Prospective Evaluation of Recombinant Herpes Zoster Vaccine in Systemic Sclerosis: Immunogenicity, Safety, and Disease Activity Outcomes

    Ana Paula Luppino-Assad1, Renata P Mello2, Ana C Medeiros-Ribeiro3, Nadia E Aikawa4, Sandra G Pasoto3, Leonard V Kupa5, Renata Miossi6, Percival D Sampaio-Barros6, Eduardo Borba7, Eloisa Bonfa7 and Clovis Artur Silva8, 1Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SAO PAULO, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Sao Paulo, Brazil, 3Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, Brazil, 4Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Sao Paulo, Brazil., Sao Paulo, Sao Paulo, Brazil, 5Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, Sao Paulo, Brazil, 6Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, 7Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, São Paulo, Brazil, 8University of São Paulo, São Paulo, São Paulo, Brazil

    Background/Purpose: Systemic sclerosis (SSc) patients are at higher risk of herpes zoster (HZ) due to underlying immune dysregulation and immunosuppressive therapies. Vaccination is a key…
  • Abstract Number: 1294 • ACR Convergence 2025

    Implementation of Pneumococcal Vaccination in Patients with Childhood-Onset Systemic Lupus Erythematous

    Kristina Ciaglia1 and Magan Fosso2, 1UT Southwestern, Children's Medical Center, and Scottish Rite for Children, Dallas, TX, 2UT Southwestern, Dallas, TX

    Background/Purpose: Pneumococcal vaccination is critical in patients with childhood-onset systemic lupus erythematosus (cSLE) due to their immunocompromised status and increased susceptibility to serious infections. Despite…
  • Abstract Number: 0211 • ACR Convergence 2025

    Initial Results From a Single-Center Quality Improvement Initiative Using the Shingrix Rheumatology Immunization Dashboard Within the Veterans Health Administration

    Alexandra Do1, Lisa Matsumoto1, Cherish Wilson2, Gary Tarasovsky3, gabriela Schmajuk4 and Jennifer Barton5, 1Oregon Health and Science University, Portland, 2UCSF / SFVA, San Francisco, CA, 3UCSF, San Francisco, 4University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, CA, 5VA Portland Health Care System/OHSU, Portland, OR

    Background/Purpose: Disease-modifying antirheumatic drugs (DMARDs) are used to treat many rheumatologic diseases by modulating the patient’s immune system. However, patients on DMARDs are more susceptible…
  • Abstract Number: 0248 • ACR Convergence 2024

    Recombinant Herpes Zoster Vaccine in a Large Cohort of Autoimmune Rheumatic Diseases Patients: An Interim Analysis of a Prospective Randomized Phase 4 Study

    Nadia Aikawa1, Ana Cristina Medeiros-Ribeiro2, Sandra Pasoto3, Leonard Kupa3, Luciana Seguro4, ANA PAULA ASSAD3, Eduardo Borba3, Carla Goncalves Schahin Saad4, Emily Figueiredo Neves Yuki3, Danieli Andrade5, Andrea Shimabuco4, Karina Bonfiglioli3, Diogo Domiciano3, Julio Moraes3, Samuel Shinjo4, Percival Sampaio-Barros4, Henrique Giardini3, Joao de Oliveira3, Isabele Antonelli3, Renata Pinheiro3, Thais Bonini3, Marta Lopes6, Clovis Silva7 and Eloisa Bonfa3, 1Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Jose Dos Campos, Brazil, 3Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 4Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil, 5University of São Paulo, São Paulo, SP, Brazil, 6Infectious Disease Department, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 7Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil

    Background/Purpose: Patients with autoimmune rheumatic diseases (ARDs) are at high risk of herpes zoster (HZ) due to their condition and treatment. The new recombinant vaccine…
  • Abstract Number: 1721 • ACR Convergence 2024

    Recombinant Zoster Vaccine Uptake in US Adults with Rheumatic Disease: A Mixed Methods Analysis

    Justin Gatwood1, Catherine McGuiness2, Marie Yasuda2, Chi-Chang Chen2, Vasudha Gupta3 and Nikita Stempniewicz1, 1GSK, Philadelphia, PA, 2IQVIA, Wayne, PA, 3IQVIA, Durham, NC

    Background/Purpose: Compared to the immunocompetent US population ≥50 years, adults with rheumatic diseases are at increased risk for herpes zoster (HZ). To address this risk,…
  • Abstract Number: 0249 • ACR Convergence 2024

    Real World Evidence on the Safety of the Adjuvanted Recombinant Zoster Vaccine in Patients with Rheumatic Diseases – Preliminary Results from a Prospective Multicenter Observational Greek Study

    Christos Koutsianas1, Anastasia Apanomeritaki2, Evgenia Mavrea1, Niki-Violeta Dimopoulou1, Maria Nitsa1, CHRISTINA TSALAPAKI1, Iro-Ioanna Giannakopoulou2 and Dimitrios Vassilopoulos1, 1Clinical Immunology-Rheumatology Unit, 2nd Department of Internal Medicine and Laboratory, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital, Athens, Greece, 2Rheumatology Clinic, General Hospital Asklepieio Voulas, Voula, Attiki, Greece

    Background/Purpose: Patients with rheumatic diseases (RD) are at increased risk for herpes zoster (HZ) due to disease -related aberrant immune response, comorbid conditions and anti-rheumatic…
  • Abstract Number: 1745 • ACR Convergence 2024

    Use of Statins and Its Association with Major Adverse Cardiovascular Outcomes with Tofacitinib versus TNF Inhibitors in a Risk-Enriched Population of Patients with Rheumatoid Arthritis

    Jon Giles1, christina Charles-Schoeman2, Maya H. Buch3, Maxime Dougados4, Zoltan Szekanecz5, Ted Mikuls6, Steven R Ytterberg7, Gary G Koch8, Kenneth Kwok9, Mary Jane Cadatal10, Sujatha Menon11, Yan Chen12, Annette M Diehl12, Jose L Rivas13, Arne Yndestad14 and Deepak L Bhatt15, 1Cedars Sinai Medical Center, Los Angeles, CA, 2UCLA Medical Center, Santa Monica, CA, 3Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, 4Université de Paris; Department of Rheumatology, Hôpital Cochin; Assistance Publique-Hôpitaux de Paris; and INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France, 5Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 6University of Nebraska Medical Center, Omaha, NE, 7Division of Rheumatology, Mayo Clinic, Rochester, MN, 8Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 9Pfizer Inc, New York, NY, 10Pfizer Inc, Manila, Philippines, 11Pfizer Inc, Groton, CT, 12Pfizer Inc, Collegeville, PA, 13Pfizer SLU, Madrid, Spain, 14Pfizer Inc, Oslo, Norway, 15Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: ORAL Surveillance (NCT02092467; a post-authorization safety study of tofacitinib 5 and 10 mg twice daily [BID] vs TNF inhibitors [TNFi]) found higher incidence of…
  • Abstract Number: 0250 • ACR Convergence 2024

    Effectiveness of Tuberculosis Preventive Treatment in Patients with Rheumatic Diseases: A Global Meta-analysis of Cohort Studies

    Beiming Wang1, Shi Chen2, Xiaoqing Liu3 and Lifan Zhang3, 1Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Division of Infectious Diseases, Department of Internal medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 3Peking union medical college hospital, Beijing, China

    Background/Purpose: As patients with rheumatic diseases (RDs) growing into a large population globally, concerns continue exist regarding the potential development of tuberculosis (TB) in this…
  • Abstract Number: 1880 • ACR Convergence 2024

    Statewide Burden of Osteoarthritis in India and Its Trend from 1990-2021: A Benchmarking Analysis

    Rafael Sanchez-Dopazo,1, malay rathod2, Ashwinikumar Shandilya3, Janmay Vala4, Eva Kalra5, Tapan Giri6, Saif Syed7, Mohit Lakkimsetti8, Juhi Patel9, VISHRANT AMIN10 and Hardik Desai11, 1Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 2Monmouth Medical Center, Rutgers University, Ewing, NJ, 3Rural Medical college. Pravara institute of medical sciences., Ahmednagar, India, 4Terna Medical College, Navi Mumbai, Maharashtra, India, 5Trident Medical Cente, Charleston, SC, 6BJ Medical College, Pune, Pune, Maharashtra, India, 7Royal college of Surgeons,Dublin,Ireland, Dublin, Dublin, Ireland, 8Mamata Medical College,Khammam, Khammam, Telangana, India, 9GMERS MEDICAL COLLEGE VALSAD, 382330, Gujarat, India, 10GMERS MEDICAL COLLEGE VALSAD, Ahmedabad, India, 11Gujarat Adani Institute of Medical Sciences, Bhuj, India

    Background/Purpose: Osteoarthritis (OA) imposes a significant health burden globally, with India experiencing substantial demographic and epidemiological changes over the past three decades. This study addresses…
  • Abstract Number: 0255 • ACR Convergence 2024

    “Rheum” to Improve: Have Patients Attending the Young Adult Systemic Erythematosus (YASLE) Clinic Received All Appropriate Vaccinations? A Quality Improvement Initiative

    Razan Al Yaarubi1, Amanda Steiman1 and Earl Silverman2, 1University of Toronto, Toronto, ON, Canada, 2Silverman, Toronto, ON, Canada

    Background/Purpose: Infections are a leading cause of morbidity and mortality in patients with childhood-onset systemic lupus erythematosus (cSLE). Vaccination is a powerful tool to prevent…
  • Abstract Number: 1884 • ACR Convergence 2024

    VIVA QI: Vaccination In Vasculitis: Applying a Quality Improvement Approach

    Stephen Williams, Stephanie Garner and Aurore Fifi-Mah, University of Calgary, Calgary, AB, Canada

    Background/Purpose: The vasculitides are rare but serious conditions that are characterized by the destructive inflammation of the blood vessels. Patients living with vasculitis are often considered…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology